Chiu-Bin Hsiao is an Infectious Disease physician affiliated with Allegheny Health Network. OpenAlex indexes 32 publications with 448 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1307 Federal St
Suite B110
Pittsburgh, PA 152124769
Telephone
412-359-3360Provider last certified this registry record 12 Oct 2020.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20242 payments
- ViiV Healthcare CompanyProgram year20222 payments
- ViiV Healthcare CompanyProgram year20216 payments$11,760openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
25.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.2%Tivicay74%Dovato14%Juluca7%Cabenuva5%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor8.6%Descovy100%Part D≥33 patients+ 3 more classes in this area
Cardiovascular
24.4%Statin11.5%Atorvastatin Calcium70%Rosuvastatin Calcium26%Pitavastatin Calcium4%Part D<11 patientsBeta blocker3.2%Metoprolol Succinate52%Carvedilol39%Metoprolol Tartrate10%Part D<11 patients+ 13 more classes in this area
Nervous system
22.9%Gabapentinoids4.2%Gabapentin80%Pregabalin21%Part D<11 patientsSSRI3.5%Trazodone Hcl37%Escitalopram Oxalate35%Sertraline Hcl20%Paroxetine Hcl9%Part D<11 patients+ 16 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 394. Safety and Effectiveness of Long-Acting Cabotegravir/Rilpivirine in People with HIV and Severe Renal Impairment (CAPRI Trial)
Open Forum Infectious Diseases
2026 - P-555. Use of Long-Acting Cabotegravir/Rilpivirine in People Living with HIV with Renal Transplantation
Open Forum Infectious Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”